[1] Mills JP,Marchaim D.Multidrug-resistant gram-negative bacteria:Infection prevention and control update[J]. Infect Dis Clin North Am,2021,35(4):969-994. [2] Polistina GE,Di Somma C,Flora M,et al.Respiratory intensive care unit management and efficacy during the COVID-19 outbreak in Naples,Italy[J]. Monaldi Arch Chest Dis,2022,93(2):2358. [3] Strich JR,Palmore TN.Preventing transmission of mueltidrug-resistant pathogens in the intensive care unit[J]. Infect Dis Clin North Am,2017,31(3):535-550. [4] Ziegler MJ,Babcock HH,Welbel SF,et al.Stopping Hospital Infections With Environmental Services (SHINE):A cluster-randomized trial of intensive monitoring methods for terminal room cleaning on rates of multidrug-resistant organisms in the intensive care unit[J]. Clin Infect Dis,2022,75(7):1217-1223. [5] 韩静静,曹霞,周晨亮,等. 多重耐药菌导致呼吸机相关性肺炎的危险因素及病原菌分析[J]. 医药导报,2019,38(10):1335-1338. [6] Shi J,Sun T,Cui Y,et al.Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality:A retrospective study in the pediatric intensive care unit[J]. BMC Infect Dis,2020,20(1):597. [7] 中华人民共和国卫生部. 医院感染监测规范[J]. 中华医院感染学杂志,2009,19(11):前插1-前插2. [8] 中华人民共和国卫生部. 医院感染诊断标准(试行)[J]. 中华医学杂志,2001,81(5):314-320. [9] 尚红,王毓三,申子瑜. 全国临床检验操作规程[M]. 人民卫生出版社,2015:1-8. [10] 中华人民共和国卫生部. 多重耐药菌医院感染预防与控制技术指南(试行)[J]. 中国危重病急救医学,2011,23(2):108-109. [11] Ali EM,Albarraq AA,Makeen HA,et al.Intravenous colistin in the treatment of multidrug-resistant gram-negative organism in tertiary hospital,Jazan,KSA[J]. J Family Med Prim Care,2021,10(1):333-338. [12] Kern WV,Rieg S.Burden of bacterial bloodstream infection-a brief update on epidemiology and significance of multidrug-resistant pathogens[J]. Clin Microbiol Infect,2020,26(2):151-157. [13] 章琦,李宝珍,郑雪梅,等. 2000—2020年中国多重耐药菌研究热点的可视化分析[J]. 中国全科医学,2022,25(24):2960-2964. [14] 彭贵霞,张华根,黄晓星,等. 2018—2020年重症监护病房医院感染病原菌分布及耐药情况分析[J]. 中华生物医学工程杂志,2021,27(6):667-673. [15] GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global,regional,and national morbidity,mortality,and aetiologies of lower respiratory infections in 195 countries,1990-2016:A systematic analysis for the Global Burden of Disease Study 2016BD 2016 Lower Respiratory Infections Collaborators. Estimates of the global,regional,and national morbidity,mortality,and aetiologies of lower respiratory infections in 195 countries,1990-2016:A systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet Infect Dis,2018,18(11):1191-1210. [16] 孙琳琳,盖凤春,赵静怡,等. 基于循证的集束化干预策略在ICU多重耐药菌感染控制中的应用研究[J]. 长春中医药大学学报,2022,38(4):448-451. [17] 陈素明,单斌,王晓明,等. 2018—2020年多中心多重耐药肠杆菌的流行病学特征及耐药性分析[J]. 中国抗生素杂志,2021,46(11):1031-1037. [18] 伊怀文,侯高林,王刚. 综合监护室患者多重耐药菌感染现状及其耐药性分析[J]. 华南预防医学,2017,43(4):356-358. [19] Liu C,Chen K,Wu Y,et al.Epidemiological and genetic characteristics of clinical carbapenem-resistant Acinetobacter baumannii strains collected countrywide from hospital intensive care units (ICUs) in China[J]. Emerg Microbes Infect,2022,11(1):1730-1741. [20] Wang M,Ge L,Chen L,et al.Clinical outcomes and bacterial characteristics of carbapenem-resistant Acinetobacter baumannii among patients from different global regions[J]. Clin Infect Dis,2023,ciad556. [21] Shimose LA,Masuda E,Sfeir M,et al.Carbapenem-resistant Acinetobacter baumannii:Concomitant contamination of air and environmental surfaces[J]. Infect Control Hosp Epidemiol,2016,37(7):777-81. [22] Tenover FC,Nicolau DP,Gill CM.Carbapenemase-producing Pseudomonas aeruginosa-an emerging challenge[J]. Emerg Microbes Infect,2022,11(1):811-814. [23] Skowron K,Grudlewska K,Kwiecińska-Piróg J,et al. Efficacy of radiant catalytic ionization to reduce bacterial populations in air and on different surfaces[J]. Sci Total Environ,2018,610-611:111-120. [24] 石婷,李甜甜,郑月娟. 金葡菌感染引发的天然免疫防御效应研究进展[J]. 中国免疫学杂志,2020,36(19):2419-2424,2428. [25] Aitken SL,Tarrand JJ,Deshpande LM,et al.High rates of nonsusceptibility to ceftazidime-avibactam and identification of new delhi metallo-β-lactamase production in Enterobacteriaceae bloodstream infections at a major cancer center[J]. Clin Infect Dis,2016,63(7):954-958. [26] 刘卫平,海云婷,杨丽芳,等. 某三级综合医院耐碳青霉烯肠杆菌科细菌流行特征及耐药性分析[J]. 中华医院感染学杂志,2020,30(19):2943-2948. [27] 王素梅,张健东,王宇凡,等. 耐碳青霉烯类肠杆菌科细菌耐药基因分型[J]. 中华医院感染学杂志,2019,29(17):2566-2570. [28] 郭磊磊,秦红英,张艺,等. 重症监护病区医院感染风险预测模型构建[J]. 中华医院感染学杂志,2019,29(8):1239-1244. |